Beet Root Research: Blood Pressure vs. Exercise Outcomes Compared

Beet Root Research: Blood Pressure vs. Exercise Outcomes Compared

Beet root appears in two largely separate research literatures that are sometimes conflated in popular writing. One line of investigation measures acute changes in blood pressure and vascular function after nitrate ingestion. The other measures exercise efficiency—how much oxygen the body needs to sustain a given workload, and how long a person can continue exercising before exhaustion. Both literatures trace back to the same underlying compound, dietary nitrate, and the same conversion pathway in the body. But they ask different questions, use different outcome measures, and support different, narrower conclusions than either is sometimes given credit for.

The shared starting point: nitrate and the nitrate–nitrite–nitric oxide pathway

Beetroot is a natural source of inorganic nitrate as well as betalain pigments. After ingestion, nitrate is concentrated in saliva and converted to nitrite by bacteria on the tongue's surface, a process called enterosalivary circulation. Nitrite can then be further converted to nitric oxide and related compounds, particularly in tissue with lower oxygen availability. This pathway is the mechanistic thread connecting both categories of research: the same swallowed dose of nitrate is proposed to affect blood vessel tone at rest and oxygen handling during muscular work, through overlapping but not identical downstream effects [PMID: 18250365].

Category one: acute blood pressure and vascular measures

The foundational human trial in this category gave healthy volunteers 500 mL of beetroot juice and tracked blood pressure alongside plasma nitrite over the following hours. Researchers observed a peak reduction in blood pressure of roughly 10/8 mmHg at about three hours post-ingestion, an effect that tracked with the rise in plasma nitrite. The same study reported that the nitrate load blunted a form of temporary endothelial dysfunction induced by an ischemic insult to the forearm and reduced platelet aggregation in blood samples taken afterward. When the researchers blocked the oral bacterial conversion step—having participants spit rather than swallow, or using antibacterial mouthwash—the blood pressure drop and antiplatelet effects disappeared, which is presented as evidence that nitrite, not nitrate itself, was the active intermediate [PMID: 18250365]. This was a single-dose, short-duration study in healthy adults, and its outcome measures were resting and post-ischemia blood pressure, endothelial function, and platelet activity—not exercise performance.

A systematic review and meta-analysis pooled sixteen randomized crossover trials conducted between 2006 and 2012, encompassing 254 participants across studies with only 7 to 30 participants each. Intervention duration across the pooled trials ranged from a single dose (2 hours) to 15 days. The pooled analysis reported a mean systolic blood pressure reduction of about 4.4 mmHg associated with inorganic nitrate or beetroot juice compared with placebo, a statistically significant effect, while the diastolic reduction (about 1.1 mmHg) did not reach significance. A meta-regression suggested that higher daily nitrate doses were associated with larger systolic reductions. The authors explicitly noted that these findings need testing in longer trials and in people at greater cardiovascular risk, since most included trials involved healthy or relatively young participants over short periods [PMID: 23596162].

A separate line of work extended acute observations to sustained supplementation. In a small crossover study of eight healthy subjects, researchers reported that plasma nitrite rose and systolic and diastolic blood pressure fell by roughly 4% not only 2.5 hours after a single beetroot juice dose but also after 5 and 15 consecutive days of daily supplementation, suggesting the blood-pressure effect did not diminish over two weeks in this small sample [PMID: 20702806]. This is still a short observation window from a small cohort, and it does not establish long-term cardiovascular outcomes.

Category two: exercise efficiency and tolerance measures

The exercise literature asks a different question: does nitrate change the metabolic cost of physical work, or how long someone can sustain high-intensity effort? An early trial in eight men used a double-blind, placebo-controlled crossover design with 500 mL/day of beetroot juice or a nitrate-free blackcurrant cordial comparator over six days. Researchers reported that the oxygen cost of moderate-intensity cycling was reduced, and that during severe-intensity exercise, the slow-rising component of oxygen uptake was smaller and time-to-exhaustion was extended (675 versus 583 seconds) compared with placebo. Systolic blood pressure was also lower in the beetroot condition in this same study, showing the two outcome categories can appear together in one dataset [PMID: 19661447].

A related study using knee-extensor exercise and phosphorus magnetic resonance spectroscopy examined the metabolic mechanism more directly. Researchers reported that beetroot juice supplementation over six days attenuated the decline in muscle phosphocreatine and reduced the rise in oxygen uptake during both low- and high-intensity exercise, and that estimated ATP turnover was lower in the supplemented condition. Time to exhaustion during high-intensity exercise improved from 586 to 734 seconds on average. The authors framed this as evidence that nitrate supplementation reduced the ATP cost of muscle force production, a specific bioenergetic mechanism distinct from a blood-pressure effect [PMID: 20466802].

Beetroot's effect on oxygen cost was also tested outside cycling. In a study comparing walking and running, researchers reported reduced oxygen cost during walking and both moderate- and severe-intensity running after six days of beetroot juice versus a nitrate-depleted placebo, with time to exhaustion during severe running increased by about 15%. Critically, this study included a nitrate-depleted version of the same beetroot juice as the placebo, which allowed the researchers to attribute the effect specifically to nitrate content rather than other compounds in beetroot [PMID: 21071588].

Translating laboratory treadmill and cycle-ergometer findings into competitive-style performance, a trial in club-level cyclists tested 4-km and 16.1-km time trials after a single 0.5 L dose of beetroot juice versus a nitrate-depleted placebo. Researchers reported that mean power output was higher in the beetroot condition despite similar oxygen uptake, consistent with improved exercise economy, and that time-trial completion times improved by about 2.8% and 2.7% for the shorter and longer trials, respectively [PMID: 21471821]. This is one of the few studies in the packet that used a performance-based outcome (time to complete a set distance) rather than a laboratory efficiency or exhaustion-time measure.

Dose and timing: what the pharmacodynamic data show

A dose-ranging study addressed a question neither of the two main outcome categories answers on its own: how much nitrate is needed, and does more always help? Ten healthy men consumed 70, 140, or 280 mL of concentrated beetroot juice, corresponding to roughly 4.2, 8.4, and 16.8 mmol of nitrate. Researchers reported that plasma nitrite rose in a dose-dependent manner, but the lowest dose (70 mL) did not measurably change exercise physiology compared with placebo. The 140 and 280 mL doses reduced oxygen uptake during moderate exercise and extended time-to-task-failure by 14% and 12%, respectively—effects of similar magnitude despite the roughly two-fold difference in nitrate content between those two doses. The authors concluded there was no additional exercise-tolerance benefit from the higher dose relative to the middle dose, even though plasma nitrite continued to rise proportionally with intake [PMID: 23640589]. This finding is important context for both outcome categories: more circulating nitrite does not appear to translate into proportionally larger downstream effects on exercise performance, at least in the dose range and population tested.

Where the two literatures diverge in method

Blood pressure studies typically measure resting or post-ischemia readings taken with a cuff, over minutes to hours, sometimes extended to two weeks of daily dosing. Exercise studies instead impose a defined physical task—cycling at a fixed workload, a set running speed, a timed trial—and measure oxygen consumption, muscle metabolite changes via imaging, or time until the subject can no longer continue. A blood pressure reduction and an oxygen-cost reduction are not the same outcome, and a study can show one without directly testing the other. Several of the exercise trials incidentally reported lower systolic blood pressure alongside their primary efficiency findings [PMID: 19661447][PMID: 21071588], which suggests the two effects can co-occur, but the study designs were built to detect exercise-related endpoints, not to characterize blood pressure as a primary outcome with matched statistical power.

Extensions to specific populations and mechanistic follow-up

Some exercise-outcome research has moved beyond healthy young adults into populations with vascular limitations, though these remain distinct, smaller studies rather than an extension of the general-population evidence base. In people with peripheral arterial disease, a randomized open-label crossover study reported that a single 500 mL dose of beetroot juice increased plasma nitrite, allowed subjects to walk 18% longer before claudication pain onset, extended peak walking time by 17%, and reduced diastolic blood pressure compared with placebo, alongside lower oxygen extraction in calf muscle tissue during exercise [PMID: 21454745]. In a separate randomized crossover trial in people with heart failure with preserved ejection fraction, a single 12.9 mmol dose of nitrate-rich beetroot juice was associated with higher peak oxygen consumption and more total work performed during maximal exercise testing, along with greater reductions in systemic vascular resistance and increases in cardiac output during exercise; however, the researchers specifically noted that exercise efficiency itself was unchanged, because both work performed and oxygen consumed rose in parallel [PMID: 25533966]. These findings, from a study registered as NCT01919177, indicate research activity in a clinical population rather than a demonstrated general benefit, and should not be read as evidence relevant to people without these diagnosed conditions.

Mechanistic work in animals has also probed how nitrate might act on the vascular side during exercise itself, rather than at rest. In a study using rats, researchers reported that five days of beetroot-juice dosing lowered mean arterial pressure during treadmill running and increased blood flow and vascular conductance to hindlimb skeletal muscle, particularly in muscle with a higher proportion of fast-twitch fibers. This animal study offers a possible physiological explanation for how nitrate might support oxygen delivery during exercise, but it was conducted in rats given a fixed dose per body weight, and its findings cannot be assumed to apply directly to human muscle physiology or translated into a claim about human exercise performance [PMID: 23070702].

A narrative review's framing of the exercise evidence

A 2014 review synthesized the human exercise-performance literature on dietary nitrate, describing a consistent pattern across the trials summarized above: nitrate supplementation increases plasma nitrite, reduces resting blood pressure, and in many but not all studies reduces the oxygen cost of submaximal exercise, with some studies also reporting improved tolerance of high-intensity effort. The review characterized these as effects that occur "in some circumstances," language that acknowledges the studies did not uniformly find performance benefits, and it discussed proposed mechanisms while calling for further clarification of dosing and population factors that determine whether an effect appears [PMID: 24791915].

What the evidence does not show

• The blood pressure trials and the exercise trials measure different outcomes; a reduction in resting blood pressure has not been shown to be equivalent to, or predictive of, a reduction in the oxygen cost of exercise or an improvement in performance, even when both appear in the same dataset.
• Most of the exercise-efficiency and time-to-exhaustion studies enrolled small samples of healthy young men (often seven to ten subjects), tested under controlled laboratory conditions with cycling, running, or knee-extensor protocols. These results have not been shown to generalize to other age groups, to women (who were underrepresented or absent in several of these trials), to untrained or older populations, or to real-world sport settings beyond the specific time-trial study described above.
• The dose-response study found no additional exercise-tolerance benefit from doubling nitrate content beyond a middle dose, despite proportionally higher plasma nitrite, indicating that higher circulating nitrite does not necessarily translate into a larger measured effect [PMID: 23640589].
• Findings in people with peripheral arterial disease or heart failure with preserved ejection fraction come from small, separate clinical trials and describe research in those specific diagnosed conditions; they do not establish a benefit for people without those conditions and are not general fitness or cardiovascular claims [PMID: 21454745][PMID: 25533966].
• The rat study of exercising muscle blood flow is animal research and cannot be presented as a demonstrated effect in human muscle or human exercise performance [PMID: 23070702].
• None of the studies summarized here evaluated a commercial supplement product, a specific finished formulation, or long-term supplementation beyond about 15 days; none assessed disease prevention, treatment, or cure, and none support a claim that beet root, in any form, treats or prevents high blood pressure or any diagnosed cardiovascular condition.
• The meta-analysis authors themselves stated that longer trials and studies in higher-cardiovascular-risk populations are needed before broader conclusions about blood pressure can be drawn [PMID: 23596162].

Reading the two bodies of evidence side by side

Neither category of research is more "proven" than the other in an absolute sense; they are simply answering different questions with different measurement tools. The blood pressure literature is anchored by a mechanistic human trial demonstrating a nitrate-to-nitrite dependency for the effect [PMID: 18250365] and supported by a modest but statistically consistent pooled effect on systolic blood pressure across sixteen small crossover trials [PMID: 23596162]. The exercise literature is built from a series of tightly controlled, small crossover studies in healthy men showing reduced oxygen cost and, in some protocols, extended time-to-exhaustion or improved time-trial performance, with dose-ranging work suggesting a plateau beyond a moderate nitrate intake [PMID: 19661447][PMID: 20466802][PMID: 21071588][PMID: 21471821][PMID: 23640589]. Where the two intersect—as in trials that measured both blood pressure and exercise oxygen cost in the same subjects—the data suggest the two effects can co-occur but were not designed to establish that one causes or predicts the other.

Selected sources

• PMID: 18250365 — Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite
• PMID: 19661447 — Dietary nitrate supplementation reduces the O2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans
• PMID: 20466802 — Dietary nitrate supplementation enhances muscle contractile efficiency during knee-extensor exercise in humans
• PMID: 20702806 — Acute and chronic effects of dietary nitrate supplementation on blood pressure and physiological responses to exercise
• PMID: 23640589 — Beetroot juice and exercise: pharmacodynamic and dose-response relationships
• PMID: 21071588 — Dietary nitrate supplementation reduces the O2 cost of walking and running
• PMID: 21471821 — Acute dietary nitrate supplementation improves cycling time trial performance
• PMID: 23070702 — Impact of dietary nitrate supplementation via beetroot juice on exercising muscle vascular control in rats
• PMID: 24791915 — Dietary nitrate supplementation and exercise performance (review)
• PMID: 23596162 — Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: a systematic review and meta-analysis
• PMID: 25533966 — Effect of inorganic nitrate on exercise capacity in heart failure with preserved ejection fraction
• PMID: 21454745 — Dietary nitrate supplementation enhances exercise performance in peripheral arterial disease

Editorial note

This article compares two distinct outcome categories within the human and animal research on beet root and dietary nitrate: acute cardiovascular/vascular measures and exercise-efficiency measures. It draws only on the studies in the approved source packet and does not extrapolate beyond their stated populations, doses, or durations. Findings in clinical populations (peripheral arterial disease, heart failure with preserved ejection fraction) are described as research in those specific groups and are not general recommendations. This is an educational discussion of ingredient-level research and does not describe, endorse, or evaluate any commercial product or formulation.

This article is for educational purposes and has not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease.